ImmunOs Therapeutics Company
ImmunOs Therapeutics AG is a biotechnology company that is currently in the clinical stage. They specialize in discovering and developing new human immunomodulatory proteins that play a role in both innate and adaptive immunity. Their goal is to create novel therapeutics that will help improve the lives of patients who suffer from serious diseases.
Investors
Estimated Revenue:
US$ 195.4 Billion
Employee Number:
11-50
Industry:
PharmTech
Founded Date:
2014
Headquarters:
Zurich